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While many studies have been devoted to investigating the homeostatic plasticity
triggered by cochlear hearing loss, the cellular and molecular mechanisms involved in
these central changes remain elusive. In the present study, we investigated the possibility
of reactive neurogenesis after unilateral cochlear nerve section in the cochlear nucleus
(CN) of cats. We found a strong cell proliferation in all the CN sub-divisions ipsilateral
to the lesion. Most of the newly generated cells survive up to 1 month after cochlear
deafferentation in all cochlear nuclei (except the dorsal CN) and give rise to a variety
of cell types, i.e., microglial cells, astrocytes, and neurons. Interestingly, many of the
newborn neurons had an inhibitory (GABAergic) phenotype. This result is intriguing since
sensory deafferentation is usually accompanied by enhanced excitation, consistent with
a reduction in central inhibition. The membrane potential effect of GABA depends,
however, on the intra-cellular chloride concentration, which is maintained at low levels in
adults by the potassium chloride co-transporter KCC2. The KCC2 density on the plasma
membrane of neurons was then assessed after cochlear deafferentation in the cochlear
nuclei ipsilateral and contralateral to the lesion. Cochlear deafferentation is accompanied
by a strong down-regulation of KCC2 ipsilateral to the lesion at 3 and 30 days post-
lesion. This study suggests that reactive neurogenesis and down-regulation of KCC2
is part of the vast repertoire involved in homeostatic plasticity triggered by hearing loss.
These central changes may also play a role in the generation of tinnitus and hyperacusis.
Keywords: neurogenesis, KCC2 transporter, hearing loss, sensorineural, tinnitus and hyperacousis, homeostatic
plasticity
INTRODUCTION
It has been suggested that homeostatic regulation applies to the averaged neural activity as many
neural processes, such as long-term potentiation and depression, can produce unstable activity,
i.e., runaway activity or no activity at all, respectively (Davis and Goodman, 1998; Turrigiano
and Nelson, 1998; Turrigiano et al., 1998). Changes compatible with homeostatic regulation of
neural activity have been reported throughout the central nervous system, including the sensory
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systems (Turrigiano, 1999; Turrigiano and Nelson, 2004; Watt
and Desai, 2010), and after various manipulations or lesions.
In the auditory modality, an enriched acoustic environment
provided for a few weeks has been shown to reduce cortical
excitability within the frequency region stimulated by the acoustic
environment (Noreña et al., 2006; Pienkowski et al., 2011,
2013). On the other hand, moderate to profound hearing loss
is accompanied by an increase of spontaneous and stimulus-
induced activity at many levels of the central auditory system,
from the cochlear nucleus (CN) up to the auditory cortex
(Kaltenbach et al., 2000; Noreña et al., 2003; Sumner et al., 2005;
Mulders and Robertson, 2009; Kalappa et al., 2014).
The repertoire of cellular and molecular mechanisms involved
in homeostatic plasticity is considerable (Burrone and Murthy,
2003; Turrigiano and Nelson, 2004; Davis, 2006; Turrigiano,
2008; Watt and Desai, 2010). Among many other mechanisms,
it has been shown that the number of post-synaptic receptors
and voltage-gated channels at the level of the axon initial
segment are precisely regulated (Turrigiano, 1999; Grubb and
Burrone, 2010; Kuba et al., 2010). It is also well known that
the balance between excitation and inhibition is finely adjusted
(Rutherford et al., 1998; Kilman et al., 2002). Moreover, reactive
neurogenesis has been demonstrated in the vestibular nuclei
after a unilateral vestibular nerve section. Interestingly, many
of the newborn neurons following the deafferentation were of
GABAergic phenotype (Tighilet et al., 2007; Dutheil et al., 2013).
At first sight, this result is surprising as sensory deafferentation
is usually followed by neural hyperexcitability (Noreña et al.,
2003; Sumner et al., 2005; Mulders and Robertson, 2009;
Kalappa et al., 2014), consistent with a reduction of inhibitory
neurotransmission (Suneja et al., 1998; Milbrandt et al., 2000;
Argence et al., 2006). Importantly, however, the polarity of GABA
action on membrane potential is regulated in adults by KCC2
co-transporters which maintain intra-cellular concentration of
chloride ion at low levels (Payne et al., 2003; De Koninck, 2007).
As a consequence, a down-regulation of KCC2 after various
manipulations have been shown to make the polarity of GABA
depolarizing (Coull et al., 2003; Boulenguez et al., 2010).
By definition, homeostatic plasticity in the nervous system
is considered to be adaptive. In some cases, however, and for
reasons that are still unclear, homeostatic plasticity may be
accompanied by collateral effects that can lead to neurological
diseases (Schaette and Kempter, 2006; Wondolowski and
Dickman, 2013; Kotas and Medzhitov, 2015). In particular, a
down-regulation of KCC2 may play a key role in the pathogenesis
of epilepsy, neuropathic pain, and spasticity (Cohen et al., 2002;
Coull et al., 2003; De Koninck, 2007; Doyon et al., 2013; Kaila
et al., 2014). In this regard, investigating how the central nervous
system maintains a stable averaged activity around a set point
level is a fundamental question in neuroscience and also a pre-
requisite to understand some pathological conditions of the
central nervous system.
The aim of the present study was to further explore the cellular
and molecular mechanisms of homeostatic plastic after unilateral
cochlear nerve section in the first relay of the central auditory
system, the CN. Tinnitus, an auditory perception not induced by
an external sound, and hyperacusis, a hypersensitivity to sound,
have been suggested to be a by-product of homeostatic plasticity
triggered by hearing loss (Schaette and Kempter, 2006; Noreña,
2011; Noreña and Farley, 2012). In this context, a secondary
goal of the present study was to gain further insight into the
mechanisms of tinnitus and hyperacusis. Neural proliferation
and the phenotype of the newborn neurons were studied in the
different sub-divisions of the CN ipsilateral and contralateral to
the lesion. Moreover, in order to investigate whether the sensory
deafferentation reverses the hyperpolarizing effect of GABA on
the membrane potential, the density of the co-transporter KCC2
on the neuronal plasma membrane was also assessed.
MATERIALS AND METHODS
Ethics Statement
All experiments were carried out in strict accordance with
the National Institutes of Health Guide for Care and Use
of Laboratory Animals (NIH Publication n◦ 80–23) revised
1996 for the UK Animals (Scientific Procedures) Act 1986 and
associated guidelines, or the Policy on Ethics approved by the
Society for Neuroscience in November 1989, and amended in
November 1993. Male European cats used in the experiments
were supplied by ISOQUIMEN (Barcelona, SPAIN) and were
housed in our animal housing facility (Fédération 3C, Centre
Saint-Charles, Aix-Marseille University) under the veterinary
and National Ethical Committee supervision (French Agriculture
Ministry Authorization: B13-055-25). Every attempt was made to
minimize both the number and the suffering of animals used in
this experiment. We selected only the most important post-UCN
time delay in light of the findings of our previous studies and in
order to limit the number of cats used. Animals were housed in a
large confined space with normal diurnal light variations and free
access to water and food.
Surgery
Adult male cats weighing between 4 and 5 kg were anesthetized
with ketamine (20 mg/kg, i.m.; Rhône-Poulenc, Mérieux,
France), received an analgesic (Tolfedine, 0.5 ml, i.m.;
Vetoquinol, Lure, France) and were kept at physiological
body temperature using a blanket. The cochlear nerve was
sectioned on the left-side at the post-ganglion level after
mastoidectomy, partial destruction of the bony labyrinth, and
surgical exposure of the internal auditory canal. Animals were
maintained under antibiotics for 7 days and analgesics for 3 days.
Implantation and Use of Osmotic
Minipumps for Drug Infusion in the
Fourth Ventricle
For the implantation and use of osmotic minipumps
containing cytosine-ß-D arabinofuranoside (AraC, S-phase-
specific antimitotic drug, Sigma–Aldrich, Saint-Quentin
Fallavier, France), Muscimol (GABAA receptor agonist, Sigma–
Aldrich, Saint-Quentin Fallavier, France) or 0.9% sodium
chloride (NaCl), a stainless steel cannula was implanted under
anesthesia into the fourth ventricle of the brain and connected
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to a subcutaneous minipump (Alzet, Alza Corporation, Palo
Alto, CA, USA; flow rate 2.5 µl/h for 30 days). A midline
incision was made through the skin and musculature in the
back of the neck, and a cannula connected to plastic tubing
was inserted between the dorsal wall of the brainstem and the
ventral face of the cerebellum and then cemented with dental
cement to the skull. The air in the system was removed by filling
up with saline, muscimol or AraC, after which the tubing was
connected to an osmotic minipump, and the skin was incised.
Muscimol was diluted to the required concentration using
artificial cerebrospinal fluid (124 mM NaCl, 5 mM KCl, 1.2 mM
KH2PO4, and 1.3 mM MgSO4) and tested for pH and adjusted
to a pH 7.0, if necessary. As detailed in the study of Gliddon
et al. (2005), we chose concentrations that provided an effect on
vestibular neurogenesis without adverse side effects on animals
(Dutheil et al., 2013). AraC was diluted in a NaCl solution at
0.13 mM, this concentration was demonstrated to inhibit totally
the mitotic activity in the deafferented vestibular nuclei without
adverse side effects on animals (Dutheil et al., 2009). Cats were
infused continuously into the cerebrospinal fluid of the fourth
ventricle during 3 or 30 days to study the consequences of the
drugs on cell proliferation, survival, and differentiation.
Study Design
A total of 24 cats were used to determine the time course
of cell proliferation in the cochlear nuclei (first experimental
protocol: Figure 1). Among these cats, 20 were subjected to
a unilateral cochlear neurectomy (UCN). They were injected
intraperitoneally (i.p.) with 5-bromo-2′deoxyuridine (BrdU:
200 mg/kg) 3 h before they were killed and perfused. BrdU is a
thymidine analog that can be incorporated into DNA during the
S phase of the cell cycle. Five post-UCN survival periods were
used: 1, 3, 7, 15, and 30 days. Each of these survival groups was
composed of four cats. The survival periods were selected based
on our previous investigations, which had showed a high number
of BrdU-immunoreactive nuclei in the deafferented vestibular
nuclei with a peak at 3 days after unilateral vestibular neurectomy
and a decrease at 30 days (Tighilet et al., 2007). A control
group was made up of four sham-operated cats. This group was
subjected to the same anesthetic procedure and surgical approach
on the cochlear nerve but without sectioning the nerve. They
were injected with the same amount and route of administration
of BrdU 3 days after sham surgery and killed 3 h later.
To study the survival and the differentiation of the
proliferating cells and to determine the effects of NaCl, muscimol
or AraC infusion after UCN on the different steps of reactive
neurogenesis (proliferation, survival, and differentiation) at the
cellular level (second experimental protocol, Figure 1), we
studied six groups of male adult cats: (i) UCN-NaCl groups,
animals underwent UCN with continuous NaCl infusion, then
received an, i.p., BrdU injection (200 mg/kg, i.p.) and were killed
at either D3 when cell proliferation reached a peak (group 1,
n = 4) or D30 to study the survival and the differentiation of the
proliferating cells (group 2, n = 4); (ii) UCN-Muscimol groups,
animals underwent UCN with continuous Muscimol infusion,
then received an, i.p., BrdU injection and were killed at D3 (group
3, n= 4) or D30 (group 4, n= 4); (iii) UCN-AraC groups, animals
underwent UCN with continuous AraC infusion, received an,
i.p., BrdU injection and were killed at D3 (group 5, n= 4) or D30
(group 6, n = 4). The two post-deafferentation survival periods
(D3 and D30) were selected on the basis of our anterior data
(Tighilet et al., 2007).
Cellular Investigations
Tissue Preparation
BrdU (10 mg/ml, Sigma, Saint Quentin Fallavier, France) was
dissolved in a solution of sodium chloride (NaCl) 0.9% heated to
56◦C and injected into animals (200 mg/kg). It has been shown
in adult rat dentate gyrus that a single dose of BrdU 100, 50, or
25 mg/kg (body weight, i.p.) labeled 60, 45, and 8% of S-phase
cells, respectively (Cameron and McKay, 2001). At 300 mg/kg,
BrdU labeled most S-phase cells and had no physiological side
effects. So, in line with the conclusions of Taupin (2007), we
considered 200 mg/kg as a saturating concentration of BrdU
for studying adult neurogenesis. BrdU doses were not likely
to generate side effects, but were sufficient to mark the cells
in S-phase synthesizing DNA. Before BrdU administration, the
cats of each group were deeply anesthetized with ketamine
dihydrochloride (20 mg/kg, i.m., Merial, Lyon, France) and killed
by 0.9% NaCl (1L per animal) then paraformaldehyde 4% (2L
per animal) transcardiac perfusion either 3 h or 27 days later
according to their experimental group. After removal from the
skull, brains were cut into several blocks containing the cochlear
nuclei. The blocks were rapidly frozen with dry ice and stored
at −80◦C. Coronal sections (40-µm-thick) were cut in a cryostat
(Leica, Rueil-Malmaison, France) for immunochemistry.
Immunochemistry
Immunochemical labeling was performed according to previously
validated protocols (Tighilet et al., 2007). Ki67 marker was used
in addition to BrdU to confirm that BrdU had been incorporated
into mitotic cells and did not correspond to dying cells or
a DNA repair mechanism (Dutheil et al., 2009). For BrdU
immunostaining, free-floating sections were first rinsed in
0.1 M PBS and incubated with 2N HCl and 0.5% Triton-X100
in PBS (30 min, 37◦C) for DNA hydrolysis. Then sections
were rinsed in 0.1 M sodium tetraborate buffer, pH 8.5 before
overnight incubation with the primary antibody at 4◦C, followed
by incubation with the secondary antibody for 1.5 h at room
temperature, and visualized using horseradish peroxidase
avidin-D (Vector). GFAP and GAD67 immunoreactivity assays
were also performed (Tighilet et al., 2007). After several rinses,
sections were mounted on gelatin-coated slides, dehydrated,
and cover-slipped in Depex mounting medium for peroxidase
staining. The differentiation of the newly generated cells was
analyzed in the group of cats injected with BrdU 3 days after UCN
and killed after 1 month. We used double immunofluorescent
stained sections incubated with BrdU and one of four antibodies:
NeuN, a post-mitotic neuronal nuclei marker expressed in
most neurons; the glial fibrillary acidic protein (GFAP), a
specific type of intermediate filament protein used as astrocyte
marker; IBA1, a ionized calcium binding adapter molecule 1,
specific to microglia and macrophages but not cross-reactive
with neurons and astrocytes; and GAD 67, the enzyme that
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FIGURE 1 | Study designs. The first protocol (#1) was elaborated using BrdU and Ki67 as cell proliferation markers to study the time-dependent effect of a UCN on
reactive cell proliferation in cochlear nuclei. Protocol number 2 (#2) was designed using a continuous infusion of NaCl, AraC, or Muscimol in the fourth ventricle to
examine alterations in newborn cell survival (BrdU marker), astrogenesis (GFAP marker), GABA cells (GAD67 marker), neuronal cells (NeuN marker), and microglial
cells (IBA1 marker) in the cochlear nuclei. BrdU, 5-bromo-2′deoxyuridine; i.p., intraperitoneal injection; GAD67, glutamic acid decarboxylase; GFAP, glial fibrillary
acidic protein; CN, cochlear nuclei; n = 4 animals per group.
catalyzes the decarboxylation of glutamate to GABA and
expressed in GABAergic neurons. Each antibody was processed
sequentially, the differentiation marker detection first and
then the BrdU labeling. For fluorescent labeling, sections were
incubated with a secondary antibody cover-slipped in Mowiol.
Differentiation of the newly generated cells was analyzed with
double-labeling analysis performed using confocal imaging with
a Zeiss LM 710 NLO laser scanning microscope equipped with
a 63x/1.32 NA oil immersion lens. The fields of view were then
examined by confocal microscopy, and 1-µm-step Z series were
obtained.
Immunochemical labeling for KCC2 was performed according
to previously validated protocols (Boulenguez et al., 2010; Bos
et al., 2013). We incubated sections overnight at 22◦C in
a mixture of affinity-purified rabbit KCC2-specific polyclonal
antibody (1:200; Millipore). We then revealed the labeling with
a mixture of donkey Cy3-conjugated rabbit-specific antibody
(1:500, Jackson Immunoresearch), and mounted coverslips
with a gelatinous aqueous medium. We analyzed the patterns
of immunolabeling by means of a laser scanning confocal
microscope (Zeiss LSM 710 META) at high magnification (Plan
Apochromat 63x 1.4 (N.A) oil immersion objective).
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Negative Control and Antibody Specificity
We performed control experiments consisting in omitting
successively one of the primary antibodies resulting in a complete
absence of cross-reactivity.
Cell Counts and Statistical Analysis
Cell counts were performed according to a previously validated
protocol (Dutheil et al., 2009, 2011). Great care was taken
not to count blood cells as BrdU+ cells. The cochlear
nuclei were identified according to Berman’s stereotaxic atlas
(Berman, 1968). BrdU+, Ki67+, GFAP+, and GAD67+ were
quantified for each subdivision of the CN, namely dorsal,
posteroventral, anteroventral, and cochlear granular cell layer
(DCN, PVCN, AVCN, and CGL, respectively). BrdU+ cells,
Ki67+cells, GFAP+ cells, and GAD67+ neurons were analyzed
in each CN on both sides (left/right in sham-operated cats
and ipsilateral/contralateral to the lesion in UCN-lesioned cats).
While it is usually straightforward to distinguish large- and
middle-sized neurons from glial cells, the distinction between
small neurons and large glial cells can be challenging. Thus,
the following criteria were used as characteristic to distinguish
small GAD 67+ neurons from GFAP+ glial cells at D30:
a centrally located nucleolus, a distinctive nucleus, visible
cytoplasm, presence of dendritic processes, and larger cell body
size. Hence, glial cells were identified by sparse cytoplasm and
smaller cell body size (Christensen et al., 2007). The cell count
was done with a Nikon microscope (Eclipse 80 i) equipped with a
motorized X-Y-Z sensitive stage and a video camera connected to
a computerized image analysis system (Mercator; Explora Nova,
La Rochelle, France). The total number of immunolabeled cells
was estimated using the optical fractionator method (West et al.,
1991). BrdU+, Ki67+, GFAP+, NeuN+, IBA1+, and GAD67+
were counted and sampled according to the so-called fractionator
principles, that is, a combination of the optical dissector, a three-
dimensional probe used for counting, and fractionator sampling,
a scheme involving the probing of a known fraction of the tissue
(West, 1993). This cell counting method has been described and
validated in previous publications (Dutheil et al., 2009, 2011).
Accordingly, the statistical analyses were evaluated by ANOVA
to test the effects of the group (UCN-NaCl, -Musimol or -
AraC), the CN sub-division (DCN, PVCN, AVCN, and CGL),
and the post-operative time on Ki 67+, BrdU+, GFAP+, KCC2+,
and GAD67+ cells and to determine whether there were any
interactions between these variables. ANOVA was followed by
post hoc analysis with the Scheffé test. Differences between sub-
divisions of CN were considered statistically significant when
p < 0.05 (StatView II, SAS software Inc., Cary, NC, USA).
Quantification of KCC2
Immunohistological Labeling
Double fluorescent labelings were captured using frame-channel
mode to avoid any cross talk between the channels. Each
optical section resulted from two scanning averages. Excitation
of the fluorochromes was performed with an argon ion laser
set at 488 nm, and a helium/neon laser set at 575 nm. At
high magnification, we only scanned the ventral CN (PVCN
and AVCN regions), which exhibited reactive neurogenesis. We
digitized stacks of 1 µm-thick optical sections.
A custom program written in Matlab R© (The Mathworks, Inc.)
was developed to analyze fluorescence at the plasma membrane of
neurons. The background or non-specific immunofluorescence,
was assessed by calculating the average fluorescence in a visually
selected area devoid of neurons or any other stained structures.
From this region, we then derived a threshold equal to the
average immunofluorescence plus three times the standard
deviation. All data were then subtracted from this threshold value
and only positive values were conserved for further analysis.
A region of interest was then drawn around the neuronal plasma
membrane of each cell body. The program calculated the average
fluorescence within the region of interest over data that were 20%
above the maximum values. This thresholding insured that all
pixels taken for calculating the average was part of the plasma
membrane and that the same criterion was used for all slices in
all conditions (otherwise, the averaged fluorescence can depend
on how large the region of interest was manually drawn around
the plasma membrane).
Also, to avoid any biases at the stage of extracting the averaged
fluorescence level in each condition, the experimenter in charge
of the analysis (M.I.S.) ignored the conditions corresponding
to the slices. We used the non-parametric Mann–Whitney test
to compare control and lesioned animals, and the lesioned and
intact side at both 3 and 30 days post-lesion in lesioned animals.
Differences were considered statistically significant at p < 0.05.
RESULTS
Time Course of BrdU and Ki67
Immunoreactivity in Cochlear Nuclei
In sham-operated cats, no BrdU-Ir nuclei were detected in the
CN. The regions of interest and the lesion-induced changes in
BrdU-Ir within the CN are illustrated in Figures 2A,B. In the
UCN group of cats, BrdU-Ir cells were exclusively restricted to the
deafferented CN. The onset of cell proliferation began 1 day after
the cochlear nerve section, peaked at 3 days and then decreased
to reach control values at 30 days post-UCN. The quantitative
analysis showed a significantly increased number of BrdU-Ir
nuclei by the first day and peaked at 3 days after UCN for the four
main CN sub-divisions (+1382% in the CGL, +2140.93% in the
AVCN, +2252.07% in the PVCN, and +2667.03% in the DCN
compared to controls, P < 0.0001). Repeated measures analysis
of variance of the data are given in Table 1. They indicate that
the number of BrdU immunoreactive cells differed significantly
with regards to group (P < 0.0001), side (P < 0.0001), and CN
(P < 0.0001). The interaction between these three factors (group,
side, and CN) was also highly significant (P < 0.0001) (Table 1).
Treatment with Muscimol significantly enhanced the number of
BrdU-Ir cells at day 3 post-lesion in all subdivisions of cochlear
nuclei compared with the UCN-NaCl group (+125% in the CGL,
+125% in the AVCN, +117% in the PVCN, and +112% in the
DCN compared to UCN-NaCl group, P < 0.0001).
The time course of Ki67 immunoreactivity was similar to that
observed for BrdU immunoreactivity (Figure 3 and Table 2).
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FIGURE 2 | Reactive cell proliferation occurs after unilateral cochlear
neurectomy (UCN) in a time-sensitive manner. (A) Photomicrographs
showing 5-bromo-2′-deoxyuridine (BrdU) immunostainings in the deafferented
cat AVCN and PVCN submitted to UCN and analyzed at post-lesion days 1,
3, and 30 (D1, D3, and D30, respectively). Animals received a BrdU injection
(i.p., 200 mg/kg body weight) 3 h before sacrifice. Scale bar: 100 µm for
lower magnification. (B) Quantitative evaluation. Histograms comparing the
mean values (±Standard Error of the Mean, SEM) of the number of
BrdU-immunopositive cells in the deafferented CN at D1, D3, and D30 after
UCN. Different letters indicate significant differences between groups of
animals and assessed by ANOVA followed by the Scheffé test, p < 0.0001,
see Table 1. a: significantly different from control, UCN d3, UCN d7, UCN
d15, and UCN d30 groups. b: significantly different from control, UCN d1,
UCN d7, UCN d15, and UCN d30 groups. Only values recorded on the
lesioned side are illustrated. n = 4 animals per group.
Ki67 marker was used in addition to BrdU to confirm that BrdU
had been incorporated into mitotic cells and did not correspond
to dying cells or a DNA repair mechanism (Dutheil et al., 2009).
In sham-operated cats, no Ki67 nuclei were detected in the CN.
A strong and significant number of Ki67 immunoreactive cells
were observed 3 days after cochlear nerve section in the whole
CN (+10616% in the CGL, +2006% in the AVCN, +2310%
in the PVCN, and +2536% in the DCN compared to controls,
P < 0.0001). In contrast, 3 days after UCN, AraC blocked the cell
proliferation in the whole CN. The number of ki67-Ir nuclei in
the CN was close to zero in cats infused with the antimitotic drug
immediately after UCN (UCN-AraC D3 group), thus confirming
the efficacy of AraC in blocking cell proliferation. The same result
was previously described in deafferented vestibular nuclei after
unilateral vestibular neurectomy and AraC infusion in the adult
TABLE 1 | Statistical analysis of the effects of unilateral cochlear
neurectomy (UCN) on the time course of cell proliferation in the cochlear
nuclei complex of adult cats.
Source of variation df F P
Number of BrdU positive cells
Group 5 7702.02 0.0001∗
Side 1 19064.15 0.0001∗
Group × side 5 7702.02 0.0001∗
Cochlear nucleus 3 248.74 0.0001∗
Group × Cochlear nucleus 15 146.74 0.0001∗
Side × Cochlear nucleus 3 248.74 0.0001∗
Group × side × Cochlear nucleus 15 146.74 0.0001∗
Repeated measures analysis of variance of the changes in the BrdU-
immunoreactive cells after UCN. The main fixed effects providing the source of
variation among animals were group (that is, sham versus unilateral- cochlear -
lesioned cats as a function of the survival postoperative period) and side (intact
versus deafferented), and cochlear nucleus (AVCN: anteroventral cochlear nucleus;
PVCN: posteroventral cochlear nucleus; CDN: dorsal cochlear nucleus and CGL:
cochlear granular cell layer). Degree of freedom (d.f.), Scheffe test (F), and
probability level (p) are reported. ∗ Indicates significant variations between variables
and/or their interactions.
cat (Dutheil et al., 2009). Repeated measures analysis of variance
of the data are given in Table 2. They indicate that the number
of Ki67 immunoreactive cells differed significantly with regards
to group (P < 0.0001), side (P < 0.0001), and CN (P < 0.0001).
The interaction between these three factors (group, side, and
CN) was also highly significant (P < 0.0001). There were no
Ki67-immunoreactive cells in any of the subdivisions of the CN
contralateral to the lesion.
Survival of BrdU Immunoreactive Cells
To study the survival of the newly generated cells stained with
BrdU at 3 days (peak of cell proliferation), the sub-groups of
animals were killed 27 days after BrdU injection. We found that
∼60% of BrdU+ cells survived in the UCN-NaCL group. These
data indicate a loss of BrdU-Ir nuclei in the CN of cats injected
at 3 days and killed 30 days after UCN compared to the group
of cats injected at the same post-lesion delay and killed 3 h later.
This reduction suggests that some of the cells that incorporated
BrdU died. Figure 4 shows the mean numbers of BrdU-Ir nuclei
that survived in the subdivisions of CN in the different groups
of cats. In the UCN-NaCl group, survival ratio was highest in
the AVCN (87.3%) than in the other CN subdivisions (48.3
and 12.2% in the PVCN and the CGL, respectively) (Table 3).
The survival ratio was very low (<2%) in the DCN (UCN-
NaCl group) and in all CN subdivisions in animals treated
with muscimol (UCN-muscimol group) and AraC (UCN-AraC
group). Repeated measures analysis of variance of the data are
given in Table 3. They indicate that the number of surviving
BrdU immunoreactive cells differed significantly with regard to
group (P < 0.0001), side (P < 0.0001), and CN (P < 0.0001). The
interaction between these three factors (group, side, and CN) was
also highly significant (P < 0.0001).
Phenotype of Newly Generated Cells
Cell differentiation was investigated by double immuno-
histochemical labeling using BrdU combined with the four
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FIGURE 3 | Ki67 immunostaining was used to confirm BrdU cell
proliferation. (A) Photomicrographs showing Ki67 immunostainings in the
deafferented AVCN and PVCN of control cats and cats infused with NaCl or
Muscimol immediately after UCN and at sacrifice (D3). Scale bar: 100 µm.
(B) Quantitative evaluation. Histograms comparing the mean values (±SEM) of
Ki67-immunopositive cells in the deafferented CN 3 days after UCN in control
cats or cats submitted to NaCl or Muscimol infusion using ANOVA followed by
the Scheffé test (p < 0.0001, see Table 2). Data from both sides of control
animals were pooled for direct comparison with the subgroups of lesioned
cats. Different letters indicate significant differences between groups of
animals in each CN: a: significantly different from control and UCN Muscimol
groups; b: significantly different from control and UCN NaCl groups. Only
values recorded on the lesioned side are illustrated. n = 4 animals per group.
specific cell type markers: GFAP, NeuN, IBA1, and GAD67 (see
Materials and Methods). The double labeling has been quantified
only at 30 days in the UCN-NaCl group since co-labeled cells
were not observed at the day 3 and no BrdU immunoreactive
cells survived in the UCN-AraC and UCN-muscimol groups.
The photomicrographs in Figure 5A show the colocalization
of BrdU+ with GFAP+, IBA1+ NeuN+, and GAD 67+ cells
observed in the deafferented AVCN at 30 days post-lesion in
the UCN-NaCl group. The fate of the newly generated cells
TABLE 2 | Statistical analysis of the effects of UCN on the cell proliferation
in the cochlear nuclei complex of adult cats.
Source of variation df F P
Number of Ki positive cells
Group 2 5293.69 0.0001∗
Cochlear nucleus 3 137.64 0.0001∗
Group × Cochlear nucleus 6 35.39 0.0001∗
Side 1 20692.91 0.0001∗
Group × side 2 5293.69 0.0001∗
Cochlear nucleus × side 3 137.64 0.0001∗
Group × side × Cochlear nucleus 6 35.39 0.0001∗
Repeated measures analysis of variance of the changes in the Ki67-
immunoreactive cells after UCN. The main fixed effects providing the source of
variation among animals were group (that is, control cats or unilateral cochlear
neurectomized cats infused with NaCl or Muscimol durind 3 days), side (intact
versus deafferented), and cochlear nucleus (AVCN: anteroventral cochlear nucleus;
PVCN: posteroventral cochlear nucleus; CDN: dorsal cochlear nucleus and CGL:
cochlear granular cell layer). Degree of freedom (d.f.), Scheffe test (F), and
probability level (p) are reported. ∗ Indicates significant variations between variables
and/or their interactions.
varied depending on the CN sub-division (Figure 5B). The
results are expressed in percent defined as the ratio between
the mean number of immunopositive-elements colocalizing a
cell type marker (GFAP, IBA1, NeuN, or GAD 67) and BrdU
relative to the total mean number of BrdU+ nuclei counted in
the areas of quantification. For the glial (GFAP and IBA1) and
neuronal marker (NeuN), the newly generated cells differentiated
approximately in similar proportion in the AVCN (20, 25, and
20%) and the PVCN (22, 23, and 20%). In the CGL, by contrast,
GFAP and IBA1 labeling were higher (40 and 45%) than NeuN
labeling (5%). The mean number of newly generated GAD67+
neurons varied depending on the CN subdivision (Figure 5B): 16,
13, and 0% in the AVCN, PVCN, and CGL, respectively. A non-
negligible percentage of cells with an undetermined phenotype
was observed in all the CN subdivisions (19% in the CVA, 22% in
the CVP, and 10% in the CGL).
KCC2
Simple visual inspection of examples shown in Figures 6 and 7
suggests that KCC2 expression is dramatically downregulated in
the ventral CN ipsilateral to the lesion at 3 and 30 days post-
lesion. The regions of interest delineated by the rectangles in
Figure 6 are shown in Figure 7 at a larger magnification, allowing
for a better view of the cell bodies and membrane fluorescence.
Contours (gray: ipsilateral to the lesion, and blue: contralateral
to the lesion) drawn around the cell body membrane define the
region of interest from which fluorescence level is derived. At
this magnification, it is again very clear that KCC2 density at the
plasma membrane is dramatically downregulated in the cochlear
nuclei ipsilateral to the lesion. The distribution of membrane
fluorescence is shown in the right column of Figure 7.
The averaged KCC2 fluorescence level for each condition
(control animals: n = 110 cells; lesioned animals, ipsilateral to
the lesion, day 3 n = 101 cells; lesioned animals, contralateral
to the lesion, day 3 n = 75 cells; lesioned animals, ipsilateral to
the lesion, day 30 n = 97 cells; lesioned animals, contralateral
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FIGURE 4 | Newborn cells generated 3 days after UCN survived up to 1 month depending on the treatment administrated. (A) Illustrations of BrdU
immunoreactivity in both the deafferented AVCN and PVCN at different time points (post-lesion D3 or D30) in UCN animals treated with NaCl-, AraC-, or
Muscimol-intra-cerebroventricular infusion. Note that in AraC treated animals, no BrdU+ cells were observed at D3 (data not shown) or D30. Scale bar: 100 µm and
n = 4 animals per group. (B) Histograms showing the effects of drug infusion (NaCl, AraC, or Muscimol) on the number of BrdU-immunopositive cells observed in
the deafferented cochlear nuclei. Only values recorded on the lesioned side are illustrated. Different letters indicate significant differences between all other groups of
animals. Analyzes were assessed by ANOVA followed by the Scheffé test for all VN and groups (p < 0.0001, see Table 3).
to the lesion, day 30 n = 85 cells) is shown in Figure 8. In
lesioned animals, the Mann–Whitney test revealed that KCC2-
related fluorescence in the ventral CN ipsilateral to the lesion is
significantly lower than fluorescence in ventral CN contralateral
to the lesion at days 3 and 30 post-lesion (p < 0.05). The level of
KCC2-related fluorescence was also significantly reduced in the
CN ipsilateral to the lesion when compared to the CN in control
animals (p < 0.05).
DISCUSSION
Cochlear Lesion-Induced Mitotic Activity
in the Deafferented Cochlear Nuclei
The present study shows an intense BrdU immunolabeling
after unilateral section of the cochlear nerve in the adult cat
that is restricted exclusively to the cochlear nuclei ipsilateral
to the lesion. The presence of Ki67-Ir cells in the CN
after UCN strongly suggests that BrdU immunolabeling is
related to mitotic activity instead of DNA repair or apoptotic
events. Cell proliferation was observed as early as 1 day post-
lesion, with a peak at 3 days, a reduction at 7 days, and
a total lack of BrdU-Ir cells at 30 days. At 1 month post-
lesion, many of the BrdU-Ir cells survived and differentiated
giving rise to microglia, astrocytes and neurons in all CN
subdivisions (except DCN). A substantial part of the newborn
neurons acquired a GABAergic phenotype, especially in the
AVCN.
Our study corroborates an earlier study that reported cell
proliferation, survival, and differentiation of the newborn cells
in the CN of rats after bilateral cochlear lesions (Zheng
et al., 2011). The two studies differ, however, on several
aspects. The peak of cell proliferation is delayed in our
study (day 3 post-lesion) compared to that of Zheng’s study
(day 2 post-lesion). Moreover, the number of newborn cells
observed at the peak of cell proliferation was much higher
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TABLE 3 | Statistical analysis of the survival of newly generated cells by
comparing cats receiving BrdU injection 3 days after UCN and perfused
3 h after (protocol 1) and those receiving BrdU at the same time but
perfused 27 days after (protocol 2).
Source of variation df F P
Number of BrdU surviving cells
Group 2 6360.35 0.0001∗
Cochlear nucleus 3 369.20 0.0001∗
Group × Cochlear nucleus 6 205.55 0.0001∗
Postoperative time 1 13207.51 0.0001∗
Group × Postoperative time 2 4296.23 0.0001∗
Cochlear nucleus × Postoperative time 3 435.34 0.0001∗
Group × Cochlear nucleus × Postoperative time 6 214.46 0.0001∗
Repeated measures analysis of variance of the changes in the BrdU-
immunoreactive cells after UCN. The main fixed effects providing the source
of variation among animals were group (unilateral cochlear neurectomized cats
infused with NaCl, Muscimol, or AraC), the survival postoperative (period 3 days
versus 30 days), side (intact versus deafferented) and cochlear nucleus (AVCN:
anteroventral cochlear nucleus; PVCN: posteroventral cochlear nucleus; CDN:
dorsal cochlear nucleus and CGL: cochlear granular cell layer). Degree of freedom
(d.f.), Scheffe test (F), and probability level (p) are reported. ∗ Indicates the significant
variations between variables and/or their interactions.
in our study compared to that reported in Zheng’s study.
Concerning the survival ratio, the two studies cannot be
compared as, unlike in Zheng’s study, our study analyzed
the different sub-divisions of CN separately. The type of
cochlear lesion can in part account for the discrepancies
between these two studies. Indeed, the cochleas are bilaterally
destroyed in Zheng’s study, which largely spares the cochlear
nerve. In our study, on the other hand, the cochlear nerve
is sectioned unilaterally. Nerve section is known to produce
dramatic effects on the cellular microenvironment in the
innervated tissue, including Wallerian degeneration and strong
inflammatory processes (Liberge et al., 2010; Gaudet et al., 2011).
This particular biochemical environment triggered by cochlear
nerve section may have promoted reactive cell proliferation in
the CN.
Cell proliferation, survival, and differentiation have
also been observed in the vestibular nuclei after unilateral
vestibular nerve section, but not after unilateral intratympanic
injection of tetrodotoxin or labyrinthectomy (Tighilet et al.,
2007; Dutheil et al., 2009, 2011). Labyrinthectomy in the
vestibular system can be considered equivalent to cochlear
destruction in the auditory system, i.e., the sensory organs
are destroyed but the vestibular nerve is left intact. These
results (cell proliferation and differentiation after cochlear
destruction but not after labyrinthectomy) may indicate a
proneness of the auditory system to reactive neurogenesis over
the vestibular system. A putatively stronger inflammatory
reaction in the central auditory system to a peripheral
lesion may account for the differences observed between
the two sensory systems (Baizer et al., 2015). Recently, cell
proliferation has been reported in the cochlear nuclei after
unilateral noise trauma (Zheng et al., 2015). This result is
consistent with the idea that even moderate cochlear lesions
FIGURE 5 | Thirty days after UCN, glial fibrillary acidic protein (GFAP) and glutamic acid decarboxylase (GAD67) immunoreactivity are differentially
expressed in the cochlear nuclei of cats submitted to a cochlear neurectomy. (A) Double immunostaining confocal analysis of differentiated newly generated
cells processed on consecutive serial sections. The BrdU+ nuclei are in red and the other markers of differentiation: GFAP+, IBA1+, NeuN+, and GAD 67+ in
green. Illustrations were made in the deafferented AVCN nucleus of cats 30 days after cochlear neurectomy. (B) Histograms illustrating the percentage of GFAP,
IBA1, NeuN, and GAD67 positive cells among the BrdU positive cells observed in the different sub-divisions of CN.
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FIGURE 6 | Examples of entire slices showing KCC2-related fluorescence in control and lesioned animals (D3 and D30 post-lesion) in the left and
right VCN (or VCN ipsilateral and contralateral side to the lesion; first and second column). The corresponding distribution of fluorescence from the slices is
shown in the third column (gray bars: left or ipsilateral to the lesion, blue bars: right or contralateral to the lesion). The region of interests delineated by gray and blue
rectangles in the first and second columns are showed in Figure 7 at higher magnification.
may trigger central modifications that are favorable to cell
proliferation.
Compared to the neurogenesis occurring spontaneously, the
high percentage of cell proliferation and survival ratio reported
in this and other studies can be surprising. However, the two
types of cell proliferation (spontaneous and reactive) are very
different. Indeed, the adult mammalian brain is considered
mostly as non-neurogenic, except in the subventricular zone of
the lateral ventricles and the subgranular zone of the dentate
gyrus. It is only in pathological conditions or after severe
injury that anti-neurogenic influences can be removed and
that cell proliferation can occur in usually non-neurogenic
regions. It is likely that the two types of cell proliferation are
governed by different mechanisms. In fine, this could explain
the high level of cell proliferation and survival observed in
the deafferented cochlear nuclei after unilateral cochlear nerve
section.
Regarding the origin of the reactive proliferating cells in the
cochlear nuclei several hypotheses can be proposed. Either they
result from a local origin, i.e., the intraparenchymental neural
precursors in the cochlear nuclei (Manohar et al., 2012) or they
migrate from other brain structures. In the present study, we
observed cell proliferation as early as 1 day post-lesion, with
a peak at 3 days. The precociousness of the cell proliferation
suggests a local origin of the precursors.
While many of the newborn cells survive in the ventral
CN 30 days after the cochlear nerve section, there were no
surviving cells in the DCN. Moreover, the treatment with the
GABAA agonist muscimol (starting with UCN and continued
until sacrifice) does not prevent cell proliferation but inhibits
completely survival. These results raise questions concerning the
mechanisms that facilitate/prevent neuronal survival after cell
proliferation. It has been proposed that the survival of newborn
neurons is activity-dependent, requiring normal activation of
NMDA receptors and the sub-sequent influx of calcium into
the cells (Tashiro et al., 2006). However, the NMDA receptor
activity should not be abnormally strong as too much intracellular
calcium can cause cell death (Hardingham and Bading, 2003).
The origin of intra-cellular calcium, whether it comes from intra-
or extra-synaptic NMDA receptor activity, may also be important
for the fate of neural cells (Hardingham and Bading, 2003).
The absence of survival in the dorsal CN after cochlear nerve
section may result from the relatively preserved (and maybe too
large) neural activity in this nucleus. This is possibly due to
non-auditory inputs (Shore and Zhou, 2006), even after cochlear
destruction (Koerber et al., 1966). In the same vein, muscimol
could have increased neural activity (see below the functional
implications of KCC2 down-regulation) thereby leading to an
excessive increase of intracellular calcium concentration and
death of newborn neurons (Furukawa et al., 2000).
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FIGURE 7 | KCC2-related fluorescence of cells bodies in control and lesioned animals from the region of interests delineated in Figure 6 (first and
second column). The distribution of fluorescence levels from the region of interest drawn around the plasma membrane is shown in the third column (gray bars: left
or ipsilateral to the lesion, blue bars: right or contralateral to the lesion).
FIGURE 8 | Averaged KCC2-related fluorescence in control and lesioned (in CN ipsilateral and contralateral to the lesion) animals. KCC2 is strongly
downregulated on the VCN ipsilateral to the lesion.
Deafferentation Induced a
Down-Regulation of KCC2
Co-Transporters in the Ventral CN
For the first time in the auditory modality, the present study
shows that KCC2 co-transporters are dramatically downregulated
(by 50% on average) in the cochlear nuclei after unilateral
deafferentation. This reduction in KCC2 density was observed
on the membrane of the cell body as early as 3 days post-lesion
and did not recover by 30 days post-lesion. Our results are in
strong agreement with other studies showing a down-regulation
of KCC2 after stroke or other neural injuries at different locations
(spinal chord, sciatic, and vagal nerve) (Nabekura et al., 2002;
Coull et al., 2003; Boulenguez et al., 2010; Jaenisch et al.,
2010). In auditory modality, only one study investigated the
putative changes of KCC2 in auditory centers after hearing loss.
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It reported that KCC2 gene expression was unchanged after a
bilateral cochlear ablation (Vale et al., 2003). Taken together,
these results suggest that hearing loss can downregulate KCC2 in
the plasma membrane of central neurons without changing the
global expression level of these proteins.
Much effort has been devoted to understanding the regulatory
mechanisms of KCC2 activity including: their transcriptional
levels, their density in the neuronal plasma membrane and
the fine-tuning of their intrinsic transport properties. It is
known that KCC2 activity is regulated, at least in part,
by phosphorylation/dephosphorylation mechanisms (Kahle and
Delpire, 2016). The WNK-SPAK/OSR1 kinase complex has been
suggested to play an important regulatory role on cation–
chloride cotransporters. Indeed, WNKs stimulate the kinases
SPAK and OSR1, which directly phosphorylate and inhibit KCC2,
while stimulating sodium-driven cation–chloride cotransporters
(NKCC, which enhances intra-cellular chloride level) (Alessi
et al., 2014). On the contrary, the dephosphorylation of KCC2
at Thr906/Th1007 stimulates KCC2 activity by preventing the
phosphorylation of WNK1-SPAK at these sites (Rinehart et al.,
2009). Moreover, the phosphorylation of KCC2 at another site
(Ser940) by protein kinase C has been shown to raise the
membrane expression and intrinsic transport rate of KCC2 (Lee
et al., 2007; Chamma et al., 2013).
The reduction of the sensory inputs and/or the modifications
of the cellular micro-environment produced by unilateral nerve
section have somehow to be sensed by neurons triggering
a molecular cascade leading to dramatic reduction of KCC2
levels. The brain-derived neurotrophic factor (BDNF) has been
suggested as playing a role in the activity-dependent regulation
of KCC2 through neuronal TrKB receptors (Rivera et al., 2004).
Indeed, the BDNF released by activated microglia has been
shown to downregulate KCC2 (Coull et al., 2005; Ferrini and De
Koninck, 2013). Microglia, activated by various molecules such
as cytokine (Tsuda et al., 2009), up-regulates the expression of
the purinergic receptor P2X4R, which is required for synthesizing
and releasing BDNF (Ferrini and De Koninck, 2013). The
expression of BDNF is also enhanced during chronic stress
(Lippmann et al., 2007). In our unilateral vestibulocochlear
neurectomy model, we demonstrated a long-lasting activation of
the hypothalamo–pituitary–adrenal axis and an up-regulation of
BDNF and its TrKB receptor in the deafferented vestibular nuclei
(Tighilet et al., 2009). Similar results have been observed in the
CN (data not shown). After unilateral vestibular neurectomy,
we showed recently that intracerebroventricular infusion of
BDNF increases dramatically cell proliferation and survival in
the vestibular nuclei, whereas the antagonist of TrKB receptor
K252a produced the reverse. Interestingly, K252a has been shown
to upregulate the KCC2 co-transporters (Dutheil et al., 2016).
Further studies are needed to investigate whether BDNF has the
same effects in the cochlear nuclei after cochlear nerve section.
Functional Implications of Cell
Proliferation and KCC2 Down-Regulation
Previous work in our laboratory described the occurrence of
reactive neurogenesis after unilateral vestibular nerve section
(Tighilet et al., 2007; Dutheil et al., 2009, 2011). Interestingly,
this reactive neurogenesis played a critical role in restoring
the vestibular function (Dutheil et al., 2009, 2011). This
result suggests that newborn neurons can be integrated in
a functional neural network and play an adaptive role in
the vestibular recovery after peripheral damage. Newborn
neurons could have contributed to restore a normal neuronal
activity on the lesioned side (Zennou-Azogui et al., 1993; Ris
et al., 1995). In the auditory modality, many studies showed
that cochlear lesions are followed by neural hyperactivity in
the auditory centers (Kaltenbach et al., 2000; Noreña and
Eggermont, 2003; Noreña et al., 2003; Cai et al., 2009;
Mulders and Robertson, 2009; Kalappa et al., 2014). For
example, neural activity estimated from 2-deoxyglucose was
reduced 2 h post cochlear nerve section but was restored
(and even potentially enhanced) a few weeks after the
lesion (Sasaki et al., 1980). In conclusion, this study and
others suggest that reactive neurogenesis may be part of the
homeostatic mechanism repertoire rapidly triggered after sensory
deafferentation to restore a normal averaged activity in sensory
centers.
In the general context of the many resources and energy
deployed by the auditory system to restore neural activity
after deafferentation (Noreña, 2011), the differentiation of a
substantial amount of newborn neurons into the GABAergic
phenotype (i.e., inhibitory) can appear contradictory. However,
this contradiction is only apparent. Indeed, the action of
GABA on the membrane potential depends on the intra-
cellular concentration of chloride ion which is maintained at
low levels in adults by KCC2 co-transporters. By showing that
KCC2 co-transporters are strongly downregulated after cochlear
deafferentation, the present study suggests that the polarity of
GABA on membrane potential became depolarizing (Coull et al.,
2003; Boulenguez et al., 2010). In fine, this result implies that
GABAergic neurons may contribute to restore normal neural
activity after sensory deafferentation.
Finally, while the down-regulation of KCC2 in adults after
nerve injury, ischemia, inflammation, or deafferentation can be
adaptive in most cases, it may sometimes come at a price, i.e.,
it can be accompanied by abnormal neural activity resulting in
various diseases, namely autism, neuropathic pain, spasticity, and
epilepsy (Coull et al., 2003; Boulenguez et al., 2010; Jaenisch et al.,
2010; Toda et al., 2014; Sivakumaran et al., 2015). In the auditory
modality, tinnitus and hyperacusis have been suggested to be a
by-product of homeostatic mechanisms triggered by hearing loss
(Schaette and Kempter, 2006; Noreña, 2011). Tinnitus is largely
prevalent in the general population and even more so in subjects
with profound hearing loss, including subjects who underwent
cochlear nerve section surgery (Quaranta et al., 2004; Baguley
et al., 2006; Baguley and Atlas, 2007; McCormack et al., 2014).
Regarding the possible contribution of KCC2 down-regulation in
some neurological diseases, including neuropathic pain [which is
often compared to tinnitus – (Møller, 2007)], and the dramatic
decrease of KCC2 after cochlear nerve section (this study), it
is tempting to propose that down-regulation of KCC2 after
hearing loss may play a role in the generation of tinnitus and
hyperacusis.
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Clinical Relevance
The present study shows that KCC2 is downregulated after
hearing loss suggesting that GABA can become excitatory. This
result is very important as it implies that GABA agonists are
not necessarily adapted to treat neurological disorders associated
to neural hyperactivity, including tinnitus and hyperacusis.
Moreover, the putative down-regulation of KCC2 after hearing
loss may account for the mixed effects of GABA agonist on
tinnitus (Johnson et al., 1993; Jalali et al., 2009; Aazh et al., 2011).
In this context, KCC2 may represent a much more promising
pharmacotherapeutic target for treating tinnitus and hyperacusis.
This approach is being developed for treating neurological
diseases such as chronic pain (Doyon et al., 2013; Gagnon et al.,
2013; Kahle and Delpire, 2016).
Also, it is likely that the inflammatory processes in the cochlear
nuclei triggered by cochlear nerve section contribute to the
neural changes observed in this study. One can speculate that
reducing central inflammation, and/or limiting cell proliferation
and neural differentiation triggered by sensory deafferentation,
may prevent the emergence of abnormal activity, and tinnitus
and hyperacusis. A recent study from our group reported that
an antagonist of BDNF can reduce cell proliferation and survival
and up-regulate KC22 co-transporters (Dutheil et al., 2016).
This suggests that antagonizing the BDNF signaling pathway
after cochlear lesion may counteract the mechanisms resulting
in central hyperactivity and potentially those involved in the
generation of tinnitus and hyperacusis.
CONCLUSION
The present study demonstrates cell proliferation and
differentiation in the cochlear nuclei after cochlear nerve
section. It also shows a dramatic down-regulation of KCC2
in the CN after sensory deafferentation, suggesting that
GABA became excitatory. These two mechanisms add to
the vast repertoire of neural mechanisms triggered by
hearing loss thought to be homeostatic regarding neural
activity. However, these mechanisms may come at a price:
they may be involved in the generation of tinnitus and
hyperacusis.
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